SerbinCommunications

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbin.com LA / NY / UK

David Bolinsky

OncoSec Immunopulse Immunotherapy Program 

Prev Next
Previous

OncoSec Immunopulse Immunotherapy Program

medical illustration of OncoSec has developed a method for directly stimulating T-cells to aggregate within a tumor, bypassing natural checkpoint inhibition that protects tumors from the immune system. This still from the animation shows an IL-12 coding plasmid having entered a tumor cell.
Next medical illustration of OncoSec has developed a method for directly stimulating T-cells to aggregate within a tumor, bypassing natural checkpoint inhibition that protects tumors from the immune system. This still from the animation shows a T-cell approaching a tumor cell that has had its checkpoint inhibition blocked.

OncoSec Immunopulse Immunotherapy Program

OncoSec has developed a method for directly stimulating T-cells to aggregate within a tumor, bypassing natural checkpoint inhibition that protects tumors from the immune system. This still from the animation shows an IL-12 coding plasmid having entered a tumor cell.

Keywords: Animation, 3D, Advertising / Marketing, Patient Education, Web, Product Demonstration, Professional Education, Biotechnology, Cell biology / Histology, Oncology

© David Bolinsky